Myovant Sciences Ltd
NYSE:MYOV

Watchlist Manager
Myovant Sciences Ltd Logo
Myovant Sciences Ltd
NYSE:MYOV
Watchlist
Price: 26.98 USD -0.04% Market Closed
Updated: May 17, 2024

Myovant Sciences Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Myovant Sciences Ltd
Income from Continuing Operations Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Myovant Sciences Ltd
NYSE:MYOV
Income from Continuing Operations
-$183.8m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Income from Continuing Operations
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Income from Continuing Operations
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Income from Continuing Operations
-$168.2m
CAGR 3-Years
-44%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Income from Continuing Operations
-£55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Income from Continuing Operations
£30.1m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
2%

See Also

What is Myovant Sciences Ltd's Income from Continuing Operations?
Income from Continuing Operations
-183.8m USD

Based on the financial report for Dec 31, 2022, Myovant Sciences Ltd's Income from Continuing Operations amounts to -183.8m USD.

What is Myovant Sciences Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-10%

Over the last year, the Income from Continuing Operations growth was 19%. The average annual Income from Continuing Operations growth rates for Myovant Sciences Ltd have been 15% over the past three years , -10% over the past five years .